Back to Search
GABRIEL HORTOBAGYI, M.D.
M.D.
Medical Oncology Physician
NPI: 1679668396Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
E4858(TX)
Research & Publications (20)
Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
PMID 18334512·Ann Oncol·2008
8-other
A shortage of oncologists? The American Society of Clinical Oncology workforce study.
PMID 17360965·J Clin Oncol·2007
8-other
The global breast cancer burden: variations in epidemiology and survival.
PMID 16381622·Clin Breast Cancer·2005
6-review
Moving into the future: treatment of bone metastases and beyond.
PMID 16249057·Cancer Treat Rev·2005
6-review
Opportunities and challenges in the development of targeted therapies.
PMID 15052540·Semin Oncol·2004
6-review
Future directions in the endocrine therapy of breast cancer.
PMID 14535533·Breast Cancer Res Treat·2003
8-other
Challenges and opportunities for Erlotinib (Tarceva): what does the future hold?
PMID 12840800·Semin Oncol·2003
8-other
The status of breast cancer management: challenges and opportunities.
PMID 12353825·Breast Cancer Res Treat·2002
6-review
Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
PMID 12170444·Semin Oncol·2002
6-review
Novel approaches to the management of bone metastases in patients with breast cancer.
PMID 12138408·Semin Oncol·2002
6-review
Integration of docetaxel into adjuvant breast cancer treatment regimens.
PMID 12108895·Oncology (Williston Park)·2002
6-review
Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
PMID 12057044·Clin Breast Cancer·2002
6-review
Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer.
PMID 11774205·Semin Oncol·2001
6-review
Progress in systemic chemotherapy of primary breast cancer: an overview.
PMID 11773296·J Natl Cancer Inst Monogr·2001
6-review
Integration of trastuzumab into adjuvant systemic therapy of breast cancer: ongoing and planned clinical trials.
PMID 11706395·Semin Oncol·2001
6-review
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
PMID 11454891·J Clin Oncol·2001
3-trial
Adjuvant systemic therapy for early breast cancer: progress and controversies.
PMID 11448893·Clin Cancer Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1679668396
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile